13D/13G Filings - LUMOS PHARMA INC. (LUMO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-12
6:27 pm
Purchase
2024-09-3013GLumos Pharma, Inc.
LUMO
Private Advisor Group LLC744,513
9.160%
744,513increase
(New Position)
Filing
History
2024-10-25
10:43 am
Sale
2024-09-3013GLumos Pharma, Inc.
LUMO
WELLS FARGO & COMPANY
WFC
64,981
0.800%
-352,070decrease
(-84.42%)
Filing
History
2024-02-09
7:14 pm
Sale
2023-12-2913GLumos Pharma, Inc.
LUMO
GOLDMAN SACHS GROUP INC
GS
406,711
5.100%
-62,691decrease
(-13.36%)
Filing
History
2024-02-06
09:57 am
Purchase
2023-12-3113GLumos Pharma, Inc.
LUMO
WELLS FARGO & COMPANY
WFC
417,051
5.300%
417,051increase
(New Position)
Filing
History
2023-11-29
4:30 pm
Sale
2023-11-2713DNEWLINK GENETICS CORP
NLNK
Blackstone Holdings II L.P.385,683
4.900%
-82,462decrease
(-17.61%)
Filing
History
2023-06-20
06:05 am
Sale
2023-06-1613DLumos Pharma, Inc.
LUMO
Farb Daniel Stuart400,000
4.900%
-96,891decrease
(-19.50%)
Filing
History
2023-06-02
11:14 am
Sale
2023-05-3013DLumos Pharma, Inc.
LUMO
Farb Daniel Stuart496,891
6.080%
-146,447decrease
(-22.76%)
Filing
History
2023-05-25
12:10 pm
Sale
2023-05-2413DLumos Pharma, Inc.
LUMO
Farb Daniel Stuart643,338
7.870%
-116,662decrease
(-15.35%)
Filing
History
2023-02-14
6:25 pm
Unchanged
2023-02-1313DLumos Pharma, Inc.
LUMO
Farb Daniel Stuart760,000
9.070%
0
(Unchanged)
Filing
History
2023-02-06
5:43 pm
Purchase
2022-12-3013GLumos Pharma, Inc.
LUMO
GOLDMAN SACHS GROUP INC
GS
469,402
5.600%
469,402increase
(New Position)
Filing
History
2023-01-24
12:58 pm
Purchase
2023-01-2513GLumos Pharma, Inc.
LUMO
Farb Daniel Stuart760,000
9.070%
263,189increase
(+52.98%)
Filing
History
2022-02-02
2:44 pm
Unchanged
2022-01-2713GLumos Pharma, Inc.
LUMO
Farb Daniel Stuart496,811
5.940%
0
(Unchanged)
Filing
History
2022-01-31
5:34 pm
Purchase
2022-01-2713GLumos Pharma, Inc.
LUMO
Farb Daniel Stuart496,811
5.940%
496,811increase
(New Position)
Filing
History
2022-01-05
2:41 pm
Sale
2021-12-2713DLumos Pharma, Inc.
LUMO
New Enterprise Associates 14, L.P.0
0.000%
-524,030decrease
(Position Closed)
Filing
History
2021-08-30
5:21 pm
Purchase
2021-08-2013DLumos Pharma, Inc.
LUMO
SHV Management Services II LP679,909
8.100%
679,909increase
(New Position)
Filing
History
2021-05-26
3:53 pm
Sale
2021-03-2213GLumos Pharma, Inc.
LUMO
James E. Flynn161,714
1.940%
-774,577decrease
(-82.73%)
Filing
History
2021-02-12
3:56 pm
Purchase
2020-12-3113GLumos Pharma, Inc.
LUMO
Lion Point Capital LP407,192
4.900%
407,192increase
(New Position)
Filing
History
2021-02-12
12:28 pm
Purchase
2020-12-3113GLumos Pharma, Inc.
LUMO
James E. Flynn936,291
11.280%
936,291increase
(New Position)
Filing
History
2021-02-10
7:04 pm
Purchase
2020-12-3113GLumos Pharma, Inc.
LUMO
RENAISSANCE TECHNOLOGIES LLC308,812
3.720%
308,812increase
(New Position)
Filing
History
2020-03-31
5:48 pm
Purchase
2020-03-1813DLumos Pharma, Inc.
LUMO
New Enterprise Associates 14, L.P.524,030
6.300%
524,030increase
(New Position)
Filing
History
Goto 0, 1, Next